Trials / Conditions / Nephrogenic Diabetes Insipidus
Nephrogenic Diabetes Insipidus
6 registered clinical trials studyying Nephrogenic Diabetes Insipidus — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children NCT06604975 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Se NCT05190744 | Mayo Clinic | Phase 2 |
| Unknown | Decline in Renal Concentration Ability in Lithium Treated Patients NCT05307042 | Radboud University Medical Center | — |
| Completed | Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis NCT04939753 | Universitair Ziekenhuis Brussel | — |
| Recruiting | National Registry of Rare Kidney Diseases NCT06065852 | UK Kidney Association | — |
| Completed | Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus NCT00478335 | University of Colorado, Denver | N/A |